Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women
Vincent Tukei(Elizabeth Glaser Pediatric AIDS Foundation), Appolinaire Tiam(Elizabeth Glaser Pediatric AIDS Foundation), Matseliso Masitha(Lesotho Planned Parenthood Association), Tsietso Mots’oane(Ministry of Health), Masepeli Nchephe(Ministry of Health), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Ramatlapeng Thabelo(Ministry of Health), Lauren Greenberg(Elizabeth Glaser Pediatric AIDS Foundation), Heather J. Hoffman(Milken Institute), Laura Guay(Johns Hopkins University), Majoalane Mokone(Lesotho Planned Parenthood Association), Mammatli Chabela(Lesotho Planned Parenthood Association)
Cited by 68
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612